Inactivated influenza vaccine

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

LymphomaInfluenzaAsthmaMelanoma

1774 competitors in Lymphoma

#DrugCompanyPhaseTrials

1

Inactivated influenza vaccine

Sanofi

Approved

242

Blenoxane

SSequus Pharmaceuticals

Preclinical

253

Velban

EEastern Cooperative Oncology Group

Preclinical

154

Oncaspar

SServier

Preclinical

155

Wellcovorin

GGlaxo Dba Glaxosmithkline

Preclinical

46

Tafasitamab

Incyte

Preclinical

77

Nuvigil

NNuvo Research GmbH

Preclinical

18

Elitek

AAzienda U.S.L. 1 di Massa e Carrara

Preclinical

—9

Solu-Medrol

MMassachusetts Eye and Ear Infirmary

Preclinical

—10

Systemic Therapy

Bristol-Myers Squibb

Preclinical

1Show 19 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Influenza14 trials

Inactivated Influenza Vaccine Delivered by Microneedle Patch or by Hypodermic Needle

Completed·MMark Prausnitz·Phase 1·NCT02438423·100 enrolled

The Safety, Tolerance, and Immunogenicity of MAS-1-Adjuvanted Seasonal Inactivated Influenza Vaccine (MER4101)

Unknown status·NNova Immunotherapeutics Limited·Phase 1·NCT02500680·102 enrolled

Live Attenuated Influenza Vaccine (LAIV) Versus Trivalent Inactivated Influenza Vaccine in Healthy Adults 18-49 Years

Completed·SSt. Louis University·Phase 4·NCT03101462·38 enrolled

Show 11 more trials

Study of Live, Attenuated Influenza Vaccination in Preterm and Full-Term Infants

Terminated·UUniversity of Rochester·Phase 4·NCT01194297·3 enrolled

Clinical Trial of the Inactivated Influenza Vaccine (0.25ml Formulation for Pediatric Use)

Completed·HHualan Biological Engineering, Inc.·Phase 3·NCT01554826·810 enrolled

Protective Efficacy of Flublok® Quadrivalent Versus Licensed Inactivated Influenza Vaccine in Adults ≥50 Years of Age

Completed·PProtein Sciences Corporation·Phase 3·NCT02285998·9,003 enrolled

A Study of a Live Intranasal Influenza Vaccine in Children With Cancer

Completed·SSt. Jude Children's Research Hospital·Phase 1·NCT00906750·56 enrolled

Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 1/2·NCT00091702·300 enrolled

Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Whole Virion, Vero Cell Derived)

Completed·AAlachua Government Services, Inc.·Phase 1/2·NCT00289510·423 enrolled

A Study of the Immunogenicity and Safety of the 2006-2007 Influenza Vaccine

Completed·Sanofi·Phase 2·NCT00343681·120 enrolled

Immunogenicity of Twice-annual Influenza Vaccination in Older Adults in Hong Kong

Active, not recruiting·TThe University of Hong Kong·Phase 4·NCT02957890·400 enrolled

An Effectiveness Trial to Evaluate Protection of Children and Pregnant Women by Influenza Vaccine in Rural Bangladesh

Active, not recruiting·UUniversity of Bergen·Phase 4·NCT04998344·3,800 enrolled

Direct and Indirect Benefits of Influenza Vaccine Versus Placebo in Healthy Children

Completed·TThe University of Hong Kong·N/A·NCT00792051·2,800 enrolled

Post-marketing Clinical Observation of an Inactivated Influenza Split Vaccine

Completed·HHualan Biological Engineering, Inc.·N/A·NCT01568788·600 enrolled

Immunogenicity3 trials

A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Adults

Completed·Moderna·Phase 2·NCT05606965·172 enrolled

A Study to Assess the Immunogenicity and Safety of CSL's 2009 / 2010 Formulation of Enzira® Vaccine in Healthy Volunteers

Completed·SSeqirus·Phase 4·NCT00888381·120 enrolled

Safety and Immunogenicity of Flublok Quadrivalent vs IIV4 in Adults 18-49 Years of Age

Completed·PProtein Sciences Corporation·Phase 3·NCT02290509·1,350 enrolled

Immune Response1 trial

Characterizing the Human Airway Immune Response to FluMist Vaccination

Recruiting·WWashington University School of Medicine·Phase 4·NCT07177417·30 enrolled

Observational Study1 trial

Post-Marketing Observational Study of Safety Following Vaccination With Flublok® Compared to Licensed IIV in Adults

Completed·PProtein Sciences Corporation··NCT02600585·254,648 enrolled

AIN1 trial

Yearly Strain Variation Study, 2010/2011

Completed·AAlachua Government Services, Inc.·Phase 3·NCT01157702·110 enrolled

Details

Drug Info

Related News